Hackensack, NJNCT06248515Now EnrollingIRB Ready

Thymic Cancer Clinical Trial in Hackensack, NJ

Access cutting-edge thymic cancer treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.

Sponsored by Georgetown University

Quick Self-Assessment

See if you qualify for this Hackensack location

Preparing your pre-screening questions...

Expert Care in Hackensack

Access thymic cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thymic cancer treatment provided free

Apply for This Hackensack Location

Check if you qualify for this thymic cancer clinical trial in Hackensack, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hackensack

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hackensack site if eligible
  4. 4Begin participation

About This Thymic Cancer Study in Hackensack

The goal of this clinical trial is to study the effect of sacituzumab govitecan-hziy in adult patients with advanced thymoma and thymic carcinoma after progressing on at least one prior line of therapy. The main question it aims to answer is: • What is the overall response rate (ORR) in patients with advanced thymoma and thymic carcinoma? Participants will: * receive a fixed dose of 10 mg/kg given intravenously, once weekly on Days 1 and 8 of continuous 21-day treatment cycles until disease

Sponsor: Georgetown University

Who Can Participate

Inclusion Criteria

Age \>/= 18 years at time of signing informed consent form (ICF)
Ability to understand and the willingness to sign a written informed consent document
Patients with histologically confirmed advanced thymoma or thymic carcinoma
Patients who have experienced disease progression after treatment with at least one prior systemic therapy
Measurable disease per RECIST v1.1
Availability of pre-treatment tumor tissue (archival or fresh); If archival tissue is not available and a fresh biopsy is not considered safe and medically feasible by the Investigator, the patient may be approved for enrollment after consultation with the Principal Investigator
Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2
Adequate hematologic and end-organ function, defined by the following laboratory test results, obtained within 14 days prior to initiation of study treatment:
Absolute neutrophil count (ANC) \>/= 1.5 x 10\^9/L (1500/uL) without filgrastim suppo

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hackensack?

Yes, this clinical trial (NCT06248515) has an active research site in Hackensack, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thymic Cancer Treatment Options in Hackensack, NJ

If you're searching for thymic cancer treatment options in Hackensack, NJ, this clinical trial (NCT06248515) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thymic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thymic cancer clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Hackensack, NJ

See all heart attack clinical trials recruiting in Hackensack — not just this study.

Browse Heart Attack Trials in Hackensack

Ready to Join in Hackensack?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hackensack, NJ